Shelia M. Violette Homology Medicines, Inc. (FIXX) insider trading activity

FIXX Quotes by TradingView

Shelia M. Violette is Chief Scientific Officer of Homology Medicines, Inc.. Currently has a direct ownership of 58,384 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2025, when has been sold 2,990 shares (Common Stock) at a price of $1.8 per share, resulting in proceeds of $5,382. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.4K
4.87% 3M change
n/a 12M change
Total Value Held $0

Shelia M. Violette Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2025
SELL
Open market or private sale
$5,382 $1.8 p/Share
2,990 Reduced 4.87%
58,384 Common Stock
Feb 24 2025
BUY
Grant, award, or other acquisition
-
37,500 Added 37.93%
61,374 Common Stock
Oct 15 2024
BUY
Exercise of conversion of derivative security
$43,740 $7.29 p/Share
6,000 Added 20.08%
23,874 Common Stock
Oct 11 2024
BUY
Exercise of conversion of derivative security
$14,270 $3.12 p/Share
4,574 Added 20.38%
17,874 Common Stock
Oct 08 2024
BUY
Exercise of conversion of derivative security
$41,496 $3.12 p/Share
13,300 Added 50.0%
13,300 Common Stock
SMV

Shelia M. Violette

Chief Scientific Officer
Waltham, MA

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FIXX